Professor, Psychiatry and Behavioral Sciences, University of Washington School of Medicine

Psychiatry

Richard Ries practices Psychiatry. He went to medical school at Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19 in research and 29 in primary care medicine Dr. Richard K. Ries is also published. He has 100 publications published. The lastest publication: "A brief medical necessity scale for mental disorders: reliability, validity, and clinical utility.' He accepts Medicare payments and is registered with Medicare.gov.

Publications

---

• Suicide risk and associated demographic and clinical correlates among primary care patients with recent Drug use.
• User experience evaluation of a smoking cessation app in people with Serious Mental Illness.
• Addiction and suicide: A review.
• High levels of agreement between clinic-based ethyl glucuronide (EtG) immunoassays and laboratory-based mass spectrometry.
• Preliminary findings: Contingency management targeting psycho-stimulant use results in secondary decreases in smoking for severely Mentally ill adults.
• Harm reduction with pharmacotherapy for homeless people with Alcohol dependence: Protocol for a randomized controlled trial.
• Extended-release Naltrexone and Harm Reduction Counseling For Chronically Homeless People with Alcohol Dependence.
• Acceptability of contingency management among clinicians and clients within a co-occurring Mental health and substance use treatment program.
• Preventing Addiction related suicide: A pilot study.
• Randomized controlled trial of contingency management for stimulant use in community Mental health patients with serious Mental illness.
• Predictors of stimulant abuse treatment outcomes in severely Mentally ill outpatients.
• Validation of the co-occurring Disorder quadrant model.
• Substance use and PTSD symptoms in trauma center patients receiving mandated Alcohol SBI.
• Clinical prevalence and correlates of substance use in adolescent psychiatric emergency patients.
• Barriers to metabolic care for adults with serious Mental illness: provider perspectives.
• Addiction and suicidal behavior in acute psychiatric inpatients.
• Global Appraisal of Individual Needs Short Screener (GSS): psychometric properties and performance as a screening measure in adolescents.
• Substance-induced Suicidal admissions to an acute psychiatric service: characteristics and outcomes.
• Methamphetamine users in the psychiatric emergency services: a case-control study.
• Clinicians' assessments of bipolar Disorder and substance abuse as predictors of suicidal behavior in acutely hospitalized psychiatric inpatients.
• Priority actions to improve the care of persons with co-occurring substance abuse and other mental Disorders: a call to action.
• Geriatric patients improve as much as younger patients from hospitalization on general psychiatric units.
• Unlinking disability income, substance use and adverse outcomes in dually diagnosed, severely Mentally ill outpatients.
• Outcomes of managing disability benefits among patients with substance Dependence and severe mental illness.
• Predicting rehospitalization and outpatient services from administration and clinical databases.
• Use of case manager ratings and weekly urine toxicology tests among outpatients with dual diagnoses.
• The impact of prenatal Alcohol exposure on addiction treatment.
• A prospective study of 60 consecutive psychiatric consultations in a family medicine clinic.
• The effect of acute Alcohol intoxication and chronic Alcohol abuse on outcome from trauma.
• DSM-III implications of the diagnoses of catatonia and bipolar Disorder.
• Preventive care screening for adolescents--what about substance Abuse screening?
• Transcultural psychiatry on an American psychiatric ward.
• Benzodiazepine withdrawal: clinicians' ratings of carbamazepine treatment versus traditional taper methods.
• Factitious mourning: painless patienthood.
• Catatonia and autonomic Hyperactivity.
• Alcohol counseling in a general medicine clinic. A randomized controlled trial of strategies to improve referral and show rates.
• Poor interrater reliability of MECTA EEG seizure duration measurement during ECT.
• Synergistic action of alprazolam with tranylcypromine in Drug-resistant atypical depression with panic attacks.
• Antipsychotic Drugs and plasma vasopressin in normals and acute schizophrenic patients.
• Sleep disturbances in patients with mild-stage Alzheimer's disease.
• A prospective DSM-III study of 100 consecutive somatization patients.
• The prevalence of somatization in primary care.
• ECT in medication resistant schizoaffective Disorder.
• Hyperemesis gravidarum: a biopsychosocial perspective.
• Successful recruitment of elderly community-dwelling subjects for Alzheimer's disease research.
• Delayed hypertension with electroconvulsive therapy.
• Modern diagnosis Schizophrenia in hospitalized psychiatric patients.
• Psychiatric consultation-liaison service: patients, requests, and functions.
• Symptom severity and utilization of treatment resources among dually diagnosed inpatients.
• The magnitude of acute and chronic Alcohol abuse in trauma patients.
• Serial, parallel, and integrated models of dual-diagnosis treatment.
• Sleep is undisturbed in elderly, depressed individuals who have not sought health care.
• Response to diazepam in sons of Alcoholics.
• Adjunctive treatment of benzodiazepine discontinuation syndromes: a review.
• Carbamazepine treatment for benzodiazepine withdrawal.
• Dawn simulation treatment of abstinent Alcoholics with winter depression.
• A pilot assessment at one month of 17 dual diagnosis patients.
• Use of anticonvulsants in benzodiazepine withdrawal.
• Differential diagnosis and psychopharmacology of dual Disorders.
• Advantages of separating the triage function from the psychiatric emergency service.
• A foolproof method of quality assurance in the psychiatric emergency service.
• Clinical treatment matching models for dually diagnosed patients.
• Cost of comorbid Alcohol and drug problems.
• Drug and Alcohol dependence and psychiatric populations: the need for diagnosis, intervention, and training.
• A descriptive study of trauma, alcohol, and Alcoholism in young adults.
• Assertive Community Treatment for patients with chronic and severe mental illness who abuse Drugs.
• The relationship of patient-administered outcome assessments to quality of life and physician ratings: validity of the BASIS-32.
• Case manager ratings of the clinical status of dually diagnosed outpatients.
• The MOS 36-Item Short Form Health Survey: reliability, validity, and preliminary findings in schizophrenic outpatients.
• Nefazodone treatment of major depression in Alcohol-dependent patients: a double-blind, placebo-controlled trial.
• Treatment satisfaction compared with outcome in severe dual Disorders.
• Illness severity and treatment services for dually diagnosed severely Mentally ill outpatients.
• The CAGE questionnaire and the Short Michigan Alcohol Screening Test in trauma patients: comparison of their correlations with biological Alcohol markers.
• The "WAM" score: sensitivity and specificity of a user friendly biological screening test for Alcohol problems in trauma patients.
• The dually diagnosed patient with psychotic symptoms.
• Evidence for limited validity of the revised global assessment of functioning scale.
• The effects of substance use Disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
• Representative payee practices of community Mental health centers in Washington State.
• Longitudinal assessment of quality of life in acute psychiatric inpatients: reliability and validity.
• Determinants of suicidal ideation: the role of substance use Disorders.
• A psychiatrist-rated battery of measures for assessing the clinical status of psychiatric inpatients.
• Reliability and validity of screening instruments for drug and alcohol abuse in adults seeking evaluation for attention-deficit/hyperactivity Disorder.
• Linking substance Abuse services with general medical care: integrated, brief interventions with hospitalized patients.
• Managing disability benefits as part of treatment for persons with severe mental illness and comorbid drug/alcohol Disorders. A comparative study of payee and non-paye...
• Psychiatric status, quality of life, and level of care as predictors of outcomes of acute inpatient treatment.
• Shorter hospital stays and more rapid improvement among patients with schizophrenia and substance Disorders.
• A brief medical necessity scale for mental Disorders: reliability, validity, and clinical utility.
• Predictors and outcome of discharge against medical advice from the psychiatric units of a general hospital.
• Reliability and clinical utility of DSM-IV substance-induced psychiatric Disorders in acute psychiatric inpatients.
• Use of psychiatric emergency services and enrollment status in a public managed Mental health care plan.
• Barriers to identification and treatment of hazardous drinkers as assessed by urban/rural primary care doctors.
• Factors associated with high use of public mental health services by persons with borderline personality Disorder.
• Insight into Alcohol-related problems and its associations with severity of Alcohol consumption, mental health status, race, and level of acculturation in southern Tai...
• The use of administrative data as a substitute for individual screening scores in observational studies related to problematic Alcohol or drug use.
• Impact of brief interventions and brief treatment on admissions to chemical dependency treatment.
• Metabolic risk factors among medicaid outpatients with Schizophrenia receiving second-generation antipsychotics.
• Treatment of comorbid substance use and anxiety Disorders: a case study.
• Understanding and treating comorbid anxiety Disorders in substance users: review and future directions.
• Evaluation of ethyl glucuronide immunoassay urinalysis in five Alcohol-dependent outpatients.

Schools

---

• Northwestern Center Feinberg School of Medicine

• University Washington

Procedures Preformed

---

• Group Psychotherapy
• Psychiatric Evaluation
• Psychotherapy and Psychophysiological Therapy (incl. Biofeedback)

Conditions Treated

---

• Adjustment Disorder
• Alcoholism (Alcohol Dependence)
• Antisocial Personality Disorder
• Anxiety
• View All

Doctors Specialties

---

• Addiction Psychiatry
• Psychiatry

Accepted Insurances

---

• Choice Plus POS II
• Blue Card PPO
• Cigna HMO
• Cigna PPO
• Great West Healthcare-Cigna PPO
• Open Access Plus
• Commercial Insurance Company
• First Choice Health PPO
• Coop Core
• Medicaid
• Medicare MCR
• Molina
• MultiPlan PPO
• ODS Health Plan
• Preferred Provider Network PPN

Education

---

• University of Washington
• Northwestern University Feinberg School of Medicine

Hospital

---

• UW Medicine/Harborview Medical Center
• University of Washington Medical Center

Drug Facts

---

NPI NUMBER		1831227065
NPPES Provider LastName		RIES
NPPES Provider FirstName		RICHARD
NPPES Provider ZIPCode		981042420
NPPES Provider State		WA
Specialty Description		Psychiatry
Total Claim Count		1270.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1831227065
Last Name Of The Provider	RIES
First Name Of The Provider	RICHARD
View All

Similar Doctors

---

	Dr. Ryan M. Caldeiro, MD This Doctor is OpenDoctor Recommended.
	Dr. Owen R. Clark, MD This Doctor is OpenDoctor Recommended.
	Dr. Craig S. Smart, MD This Doctor is OpenDoctor Recommended.
	Dr. Ray C. Hsiao, MD This Doctor is OpenDoctor Recommended.
	Dr. Susan H. Willis, MD This Doctor is OpenDoctor Recommended.
	Dr. Kathleen A. Ang-Lee, MD
	Dr. Anne L. Buchinski, MD This Doctor is OpenDoctor Recommended.
	Dr. Scot N. Gibson, MD
	Dr. Robert L. Bergman, MD
	Dr. Joseph P. Reoux, MD This Doctor is OpenDoctor Recommended.
	Dr. Samir W. Aziz, MD This Doctor is OpenDoctor Recommended.
	Dr. Craig D. Jaffe, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael L. Ruthrauff, MD This Doctor is OpenDoctor Recommended.
	Dr. James F. Roark Jr., MD
	Dr. Jennifer R. Velander, MD
	Dr. Edward K. Rynearson, MD This Doctor is OpenDoctor Recommended.
	Dr. Liza K. Partlow Lohse, MD This Doctor is OpenDoctor Recommended.
	Dr. Micah E. Croft, MD This Doctor is OpenDoctor Recommended.
	Dr. George T. Bondurant, MD This Doctor is OpenDoctor Recommended.
	Dr. Wesley C. Ryan, MD
	Dr. Alexandra M. Bright, MD This Doctor is OpenDoctor Recommended.
	Dr. Ashley D. Davidson, MD
	Dr. Joshua D. Bess, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog